More Globe Newswire

View Older Stories View Newer Stories

Apr 7, 2026 04:10AM Prepayments (CK93) - Nykredit Realkredit A/S
Apr 7, 2026 04:02AM Columbus – Weekly report on share buyback
Apr 7, 2026 04:02AM Investeringsforeningen Sparinvest suspenderer handel af alle afdelinger
Apr 7, 2026 04:00AM Majority homeowners staying put, limiting first-time buyers: survey
Apr 7, 2026 03:59AM Værdipapirfonden Sparinvest suspenderer midlertidig handel med alle afdelinger
Apr 7, 2026 04:00AM Danske Bank share buy-back programme: transactions in week 14
Apr 7, 2026 04:00AM Wolters Kluwer accelerates AI leadership with AI Center of Excellence and “FAB” platform
Apr 7, 2026 04:00AM Oculis to Participate in Upcoming Investor Conferences
Apr 7, 2026 04:00AM Call for Nominations: 2026 Global Citizen Award
Apr 7, 2026 03:58AM Transactions in connection with share buyback programme
Apr 7, 2026 03:56AM Investeringsforeningen SparDanmark Invest suspenderer midlertidig handel med alle afdelinger
Apr 7, 2026 03:46AM AL Sydbank A/S share buyback programme: transactions in week 14
Apr 7, 2026 03:44AM Investeringsforeningen Nykredit Invest Balance suspender handel med alle afdelinger
Apr 7, 2026 03:39AM Correction: Share repurchase programme: Transactions of week 14 2026
Apr 7, 2026 03:30AM CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
Apr 7, 2026 03:21AM Tryg - Transactions in connection with share buyback programme
Apr 7, 2026 03:05AM EFM Global Calls on Live Events Industry to Prepare as Europe Moves to Digital ATA Carnets on June 1, 2026
Apr 7, 2026 03:00AM SonoNeu exits stealth as key part of US Government-funded research program worth up to $41.3m to advance sonogenetics into clinic
Apr 7, 2026 03:00AM Earweiss Partners with USound to Power Next-Generation Hearables with MEMS Speaker Technology
Apr 7, 2026 03:00AM Sonoco to Increase Paperboard, Tube and Core Prices in EMEA Region
Apr 7, 2026 03:00AM Earweiss Partners with USound to Power Next-Generation Hearables with MEMS Speaker Technology
Apr 7, 2026 02:39AM Renk Group AG: Release according to Article 40 (1) of the WpHG (the German Securities Trading Act) with the objective of Europe-wide distribution
Apr 7, 2026 02:36AM Share buyback programme – week 14
Apr 7, 2026 02:33AM Presentation of INVL Technology
Apr 7, 2026 02:32AM Announcement of the net asset value of INVL Technology as of 31 December 2025
Apr 7, 2026 02:32AM Audited results of INVL Technology of 2025
Apr 7, 2026 02:30AM Ex-dividend Date
Apr 7, 2026 02:30AM ING has terminated sale agreement for its Russian business
Apr 7, 2026 02:18AM Preliminary data on early redemptions (prepayments)
Apr 7, 2026 02:00AM Notice of 2026 AGM
Apr 7, 2026 02:04AM Crypto Exchange Poloniex Announces $100 Million User Protection Fund
Apr 7, 2026 02:01AM Share repurchase programme: Transactions of week 14 2026
Apr 7, 2026 02:01AM DIRECTOR / PDMR NOTIFICATION
Apr 7, 2026 02:00AM Pharming Group to participate in April investor conferences
Apr 7, 2026 02:00AM Progress on share buyback programme
Apr 7, 2026 02:00AM Notice of 2026 AGM
Apr 7, 2026 02:00AM SPINEWAY : Minutes of the General Meeting of April 2, 2026
Apr 7, 2026 02:00AM Issue of Equity and Total Voting Rights
Apr 7, 2026 02:00AM NBPE Announces Transaction in Own Shares
Apr 7, 2026 02:00AM OSB GROUP PLC - Transaction in Own Shares
Apr 7, 2026 02:00AM Agentic Commerce Set to Generate $1.5 Trillion Globally by 2030, as Payments Infrastructure Leaders Revealed
Apr 7, 2026 02:00AM NOTICE OF ANNUAL GENERAL MEETING OF JLT MOBILE COMPUTERS
Apr 7, 2026 01:17AM Symra Beats Start-Up Schedule, DNO Boosts North Sea Output
Apr 7, 2026 01:02AM Kiniero Quarter 1 Production Update
Apr 7, 2026 01:02AM Proxy form for Annual General Meeting 2026 (in Swedish)
Apr 7, 2026 01:00AM Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
Apr 7, 2026 01:00AM Biotalys Achieves First Milestone in Bioinsecticide Partnership with Syngenta
Apr 7, 2026 01:00AM TextMagic group’s sales results for Q1 2026
Apr 7, 2026 01:00AM Start of Day Message
Apr 7, 2026 01:00AM Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
View Newer Stories View Older Stories